Pharmaceuticals
HC backs Novartis, bars Cipla from selling lung drug copy
By By Jagdeep Worah | 10 Jan 2015
In a blow to those suffering from lung and respiratory diseases, the Delhi High Court on Friday restrained domestic firm Cipla from marketing its affordable generic version of respiratory drug Onbrez, ruling in favour of multinational Novartis

